The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

Wisconsin DHS Respiratory Disease Epidemiologist Thomas Haupt told the Journal Sentinel in an email the department's most ...

Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...

FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk.

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

Positive tests for respiratory illnesses have been steadily climbing for weeks in British Columbia, especially for flu and ...

Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...

Georgia was one of 18 states with "high" or "very high" levels in wastewater, according to CDC monitoring. Here's what to ...